We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Tibotec Seeks Traditional Approval for Intelence
Tibotec Seeks Traditional Approval for Intelence
February 6, 2009
After receiving accelerated approval last year for Intelence, a combination HIV therapy, Tibotec has followed up with an application for traditional approval, which would remove some of the restrictions on marketing the drug.